Homepage > Company > Media > Pharma News > 2021 > Nearly 60% of Americans at least partially vaccinated against COVID-19 - CDC

Nearly 60% of Americans at least partially vaccinated against COVID-19 - CDC

(Reuters) - Nearly 60% of the U.S. population has received at least one dose of a COVID-19 vaccine as of Monday morning, the U.S. Centers for Disease Control and Prevention said.

The agency said 195,222,906 people, or 58.8% of the total population, have had at least one shot while 157,888,305 people, or 61.1% of the adult population, are fully vaccinated.

The United States had administered 351,933,175 doses of COVID-19 vaccines in the country as of Monday morning and distributed 407,560,705 doses.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Monday.

Aug 09, 2021

https://www.investing.com/

Read also

uniQure Staggers as FDA Questions Data for Huntington’s Gene Therapy Candidate

Agency torpedoes company's plans to submit BLA for gene therapy AMT-130 in Q1 2026.

Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn.

Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges

Femasys (FEMY) on Monday said that the FDA approved continuation of the final phase of its FemBloc pivotal trial, sending shares 25% higher in premarket trading.

Praxis announces

Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback